The phagocyte specific protein S100A12 as a novel biomarker in Muckle-Wells-Syndrome before and during therapy with Anakinra and Canakinumab (ACZ885)

by Wittkowski H, Kuemmerle-Deschner JB, Gramlich K, Tzaribachev N, Felix SD, Jung T, Roth J, Rordorf C, Foell D
Published 2008-09-01

12.4 ACZ885 (canakinumab), a new IL-1 beta blocking monoclonal antibody provides long-lasting remission in children with cryopyrin associated periodic syndrome (CAPS)

by Kümmerle-Deschner J, Blank N, Roesler J, Ramos E, Tzaribachev N, Gramlich K, Well C, Felix SD, Rordorf C, Jung T
Published 2008-09-01